Polypharmacy in psychiatry

被引：0
|
作者：
Thomas, ML [1 ]
机构：
[1] Cent State Hosp, Clin Psychopharmacol, Petersburg, VA USA
来源：
PSYCHIATRIC SERVICES | 2003年 / 54卷 / 08期
关键词：
D O I：
10.1176/appi.ps.54.8.1174
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1174 / 1174
页数：1
相关论文
共 50 条
  • [31] Polypharmacy and potentially inappropriate medications (PIMS) in older adults referred to a liaison psychiatry service
    Akpan, Anietie
    Longe, Omolade
    [J]. BJPSYCH OPEN, 2021, 7 : S306 - S307
  • [32] Polypharmacy in Psychiatry: An In-depth Examination of Drug-drug Interactions and Treatment Challenges
    Shekho, Devank
    Mishra, Ritika
    Kamal, Raj
    Khurana, Divya
    Chauhan, Abhishek
    Awasthi, Ankit
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (21) : 1641 - 1649
  • [33] Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatry
    Wolff, Jan
    Hefner, Gudrun
    Normann, Claus
    Kaier, Klaus
    Binder, Harald
    Hiemke, Christoph
    Toto, Sermin
    Domschke, Katharina
    Marschollek, Michael
    Klimke, Ansgar
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (09) : 1258 - 1268
  • [34] Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia
    Stassen, H. H.
    Bachmann, S.
    Bridler, R.
    Cattapan, K.
    Herzig, D.
    Schneeberger, A.
    Seifritz, E.
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2022, 272 (04) : 603 - 619
  • [35] INTEGRATION OF NEUROPSYCHOLOGICAL AND BEHAVIORAL NEUROLOGICAL ASSESSMENT IN PSYCHIATRY - A CASE EXAMPLE INVOLVING BRAIN INJURY AND POLYPHARMACY
    WEINSTEIN, CS
    SEIDMAN, LJ
    AHERN, G
    MCCLURE, K
    [J]. PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, 1994, 57 (01): : 62 - 76
  • [36] Evaluation of Risk Factors for Antipsychotic Polypharmacy in Inpatient Psychiatry Units of a Community Hospital: A Retrospective Analysis
    Shreedhar Paudel
    Rabin Dahal
    Joseph Mathias
    Sushrusha Arjyal
    Liliana Markovic
    [J]. Community Mental Health Journal, 2019, 55 : 750 - 754
  • [37] Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service
    Buber, Ahmet
    Gavcar, Erdal Gorkem
    Basay, Omer
    Unlu, Gulsen
    Kabukcu Basay, Buerge
    Senol, Hande
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (02) : 69 - 75
  • [38] DEPRESCRIBING IN CHILD AND ADOLESCENT PSYCHIATRY: WHERE, WHEN, AND HOW TO SAFELY REDUCE POLYPHARMACY IN CLINICAL SETTINGS
    Bellonci, Christopher
    Carlson, Gabrielle A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S37 - S37
  • [39] Potential benefit of polypharmacy of Long acting injectable drugs: retrospective data from a psychiatry hospital
    Kenar, A. N. Inci
    Mert, A.
    Matsar, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S462 - S463
  • [40] Evaluation of Risk Factors for Antipsychotic Polypharmacy in Inpatient Psychiatry Units of a Community Hospital: A Retrospective Analysis
    Paudel, Shreedhar
    Dahal, Rabin
    Mathias, Joseph
    Arjyal, Sushrusha
    Markovic, Liliana
    [J]. COMMUNITY MENTAL HEALTH JOURNAL, 2019, 55 (05) : 750 - 754
12345